CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 63 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $317,000 | -27.0% | 150,000 | 0.0% | 0.04% | -51.2% |
| Q1 2021 | $434,000 | -32.4% | 150,000 | -50.0% | 0.08% | +23.1% |
| Q4 2020 | $642,000 | -65.4% | 300,000 | 0.0% | 0.06% | -87.5% |
| Q3 2020 | $1,857,000 | -3.7% | 300,000 | 0.0% | 0.52% | -16.6% |
| Q2 2020 | $1,929,000 | +54.9% | 300,000 | 0.0% | 0.62% | -13.4% |
| Q1 2020 | $1,245,000 | -29.8% | 300,000 | 0.0% | 0.72% | -15.6% |
| Q4 2019 | $1,773,000 | +9.4% | 300,000 | 0.0% | 0.85% | -22.9% |
| Q3 2019 | $1,620,000 | -33.1% | 300,000 | 0.0% | 1.10% | -31.0% |
| Q2 2019 | $2,421,000 | +1.9% | 300,000 | 0.0% | 1.60% | -14.4% |
| Q1 2019 | $2,376,000 | +81.2% | 300,000 | 0.0% | 1.87% | +48.4% |
| Q4 2018 | $1,311,000 | – | 300,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |